These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12627044)

  • 21. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.
    Pickar JH; Yeh IT; Wheeler JE; Cunnane MF; Speroff L
    Fertil Steril; 2003 Nov; 80(5):1234-40. PubMed ID: 14607581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dosage esterified estrogens opposed by progestin at 6-month intervals.
    Ettinger B; Pressman A; Van Gessel A
    Obstet Gynecol; 2001 Aug; 98(2):205-11. PubMed ID: 11506834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
    Castelo-Branco C; Puerto B; Durán M; Gratacós E; Torné A; Fortuny A; Vanrell JA
    Maturitas; 1994 May; 19(1):59-65. PubMed ID: 7935033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal progesterone cream as an alternative progestin in hormone therapy.
    Leonetti HB; Landes J; Steinberg D; Anasti JN
    Altern Ther Health Med; 2005; 11(6):36-8. PubMed ID: 16320858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agreement in assessing endometrial pathology: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Legault C; Espeland MA; Wasilauskas CH; Bush TL; Trabal J; Judd HL; Johnson SR; Greendale GA
    J Womens Health; 1998 May; 7(4):435-42. PubMed ID: 9611701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial changes according to hormone replacement therapy schedule.
    Carranza-Lira S; Martínez-Chéquer JC; Santa Rita MT; Ortiz de la Peña A; Pérez Y; Fernández RL
    Menopause; 1998; 5(2):86-9. PubMed ID: 9689201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.
    Burch D; Bieshuevel E; Smith S; Fox H
    Maturitas; 2000 Feb; 34(2):155-60. PubMed ID: 10714910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
    Saure A; Planellas J; Poulsen HK; Jaszczak P
    Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.
    Woodruff JD; Pickar JH
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1213-23. PubMed ID: 8178840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens.
    Simon JA; Symons JP;
    Menopause; 2001; 8(5):321-7. PubMed ID: 11528357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
    Battino S; Ben-Ami M; Geslevich Y; Weiner E; Shalev E
    Gynecol Obstet Invest; 1996; 42(2):113-6. PubMed ID: 8878716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
    Proudler AJ; Cooper A; Whitehead M; Stevenson JC
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
    King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
    J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.